General Information of Drug (ID: DMPJLS4)

Drug Name
CAD-1883 Drug Info
Indication
Disease Entry ICD 11 Status REF
Ataxic disorder 8A03 Phase 1/2 [1]
Cross-matching ID
PubChem CID
132207249
TTD Drug ID
DMPJLS4

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AP-30663 DMJLMEF Atrial fibrillation BC81.3 Phase 1/2 [1]
CAD-1833 DMA1QUC Essential tremor or related tremors 8A04.1 Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calcium-activated potassium channel KCa2 (KCNN) TTKU9YD NOUNIPROTAC Activator [1]

References

1 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)